Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
12.85
+0.08 (0.63%)
At close: Nov 20, 2024, 4:00 PM
12.65
-0.20 (-1.56%)
Pre-market: Nov 21, 2024, 4:18 AM EST
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $168.91 million as of November 21, 2024. Its market cap has increased by 23.91% in one year.
Market Cap
168.91M
Enterprise Value
163.09M
1-Year Change
23.91%
Ranking
Category
Stock Price
$12.85
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $168.91M, an increase of 145.91%. That is a compound annual growth rate of 24.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 168.91M | 24.97% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stereotaxis | 172.00M |
| DiaMedica Therapeutics | 171.92M |
| Heron Therapeutics | 170.35M |
| The Joint | 170.06M |
| Adaptimmune Therapeutics | 169.99M |
| Verastem | 168.68M |
| scPharmaceuticals | 168.13M |
| Actuate Therapeutics | 167.58M |